PharmacoMicrobiomics: The Drug-Microbiome Portal

How Bugs Modulate Drugs?

Launched on 11/11/11; Current Release 1.5 (21 Mar 2021): Spring of Hope! (Release History)

Detailed View

28
Summary Gut microbes (currently unknown members) affect diadzein's metabolic processing.
Gut
diadzein (PubChem CID: 5281708)
unknown
17605343
affect metabolic processing
Daidzein (4',7-dihydroxyisoflavone), a soy phytoestrogen, is a weakly estrogenic compound. Biotransformation of daidzein by the human gut microbiota after ingestion converts it to either the highly estrogenic metabolite, equol, or to nonestrogenic metabolites.

Browse Drug-Microbiome Relationship
Home